Trial intelligence / Profile preview

Propranolol in Infantile Capillary Hemangiomas

NCT00744185Phase 3Terminated

Sponsor
Centre Hospitalier Universitaire de Bordeaux
Start
Oct 2008
Primary completion
Apr 2010
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of propranolol in capillary hemangioma, sponsored by Centre Hospitalier Universitaire de Bordeaux. Started Oct 2008; status: terminated.

02

Drugs

propranolol
03

Conditions

capillary hemangioma

Beyond the preview

Go deeper on NCT00744185.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00744185.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call